[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367059-105":59,"doc-detail-367059-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-and-clinical-validation-of-high-hsp60-expression-predicts-poor-prognosis-in-patients-with-ovarian-cancer","Identification and Clinical Validation of High HSP60 Expression Predicts Poor Prognosis in Patients with Ovarian Cancer","","Heat shock protein 60 (HSP60) expression in ovarian cancer is evaluated for clinical significance and prognostic value. The study enrolls 260 ovarian cancer patients diagnosed between 2017 and 2019 and uses immunohistochemistry to classify tumors into high- and low-HSP60 groups. Correlations with clinicopathological features are assessed, and Kaplan–Meier survival curves plus Cox regression analyze overall survival and disease-free survival. High HSP60 associates with more aggressive disease and independently predicts poorer outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-and-clinical-validation-of-high-hsp60-expression-predicts-poor-prognosis-in-patients-with-ovarian-cancer/367059/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-and-clinical-validation-of-high-hsp60-expression-predicts-poor-prognosis-in-patients-with-ovarian-cancer/367059.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the objective of this study on HSP60 in ovarian cancer?","Question",{"text":112,"@type":113},"The study investigates the clinical significance of HSP60 expression in ovarian cancer and evaluates its correlation with patient survival outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was HSP60 expression measured and grouped in the study?",{"text":117,"@type":113},"Immunohistochemistry assessed HSP60 expression in tumor tissues, and patients were categorized into high- or low-HSP60 expression groups based on staining intensity.",{"name":119,"@type":110,"acceptedAnswer":120},"What relationship does high HSP60 expression have with prognosis?",{"text":121,"@type":113},"High HSP60 expression is significantly associated with shorter overall survival and disease-free survival, and multivariate Cox analysis identifies HSP60 as an independent prognostic factor.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367059,1790535931,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","International Journal of General Medicine  \n Open Access Full Text Article  \nORIGINAL RESEARCH  \nIdentification and Clinical Validation of High HSP60 Expression Predicts Poor Prognosis in Patients with Ovarian Cancer  \nMin Zheng 1 , *, Shaoxing Li 1 , *, Jie Deng 1 , Chaolin Huang 1 , Hua Zhang2  \n1Department of Gynecology and Obstetrics, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, People’s Republic of China; 2Department of Rehabilitation Medicine, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Hua Zhang; Chaolin Huang, Department of Gynecology and Obstetrics, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, No. 278, The Middle Section of Baoguang Avenue, Xindu District, Chengdu City, Sichuan Province, 610500, People’s Republic of China, Email [2508034576@qq.com](2508034576@qq.com); [huangchaolin1006@163.com](huangchaolin1006@163.com)  \n\n| Objective: This study aimed to investigate the clinical significance of heat shock protein 60 (HSP60) expression in ovarian cancer and evaluate its correlation with patient survival outcomes.\u003Cbr>Methods: A total of 260 ovarian cancer patients diagnosed between 2017 and 2019 were enrolled. Immunohistochemistry was performed to assess HSP60 expression in tumor tissues. Patients were categorized into high-or low-HSP60 expression groups based on immunohistochemical staining intensity. The correlation between HSP60 expression status and the clinicopathological features of ovarian cancer patients was analyzed. Kaplan-Meier survival curves and Cox regression models were utilized to evaluate overall survival and disease-free survival.\u003Cbr>Results: HSP60 expression was significantly higher in ovarian cancer tissues compared to normal ovarian tissues. High HSP60 expression was associated with larger tumor size, advanced FIGO stage, and increased lymph node metastasis. Patients with high HSP60 expression exhibited significantly shorter overall survival and disease-free survival than those with low expression. Multivariate Cox analysis identified HSP60 as an independent prognostic factor for both overall survival and disease-free survival. Conclusion: High HSP60 expression is associated with poor prognosis and aggressive tumor characteristics in ovarian cancer. HSP60 may serve as a valuable biomarker for prognosis and a potential therapeutic target. Further randomized clinical trials are warranted to explore its role in ovarian cancer progression and treatment strategies.\u003Cbr>Keywords: HSP60, ovarian cancer, disease-free survival, overall survival, Cox regression model |\n| --- |\n| Introduction\u003Cbr>Ovarian cancer is one of the most lethal gynecologic malignancies globally, with an estimated 324,398 new cases and 206,839 deaths reported in 2022.1 This high mortality rate is primarily attributed to the disease’s asymptomatic nature in its early stages, resulting in over 70% of patients being diagnosed at advanced stages (FIGO stage III or IV) .2–4 Despite advancements in surgical techniques and systemic therapies, the prognosis remains poor due to high recurrence rates and resistance to chemotherapy.5,6 Therefore, identifying reliable biomarkers that can improve early detection, prognostic evaluation, and therapeutic outcomes is critical.\u003Cbr>Heat shock proteins (HSPs) are a family of highly conserved molecular chaperones that maintain cellular homeostasis under stressful conditions, such as exposure to toxins or heat shock.7,8 Among these, Heat Shock Protein 60 (HSP60) plays a critical role in protein folding, mitochondrial function, and cellular survival. Recent studies suggest that HSP60 is overexpressed in multiple cancers, including breast, lung, and colorectal cancers, where it is associated with tumor progression, resistance to apoptosis, and metastasis.9–11 Previous studie","cbCaibOiIIfZLovp","https://ap.wps.com/l/cbCaibOiIIfZLovp","pdf",1619446,"English","# Objective\n# Methods\n## Patients\n## Immunohistochemistry\n## Survival and regression analyses\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"What is the objective of this study on HSP60 in ovarian cancer?\",\"answer\":\"The study investigates the clinical significance of HSP60 expression in ovarian cancer and evaluates its correlation with patient survival outcomes.\"},{\"question\":\"How was HSP60 expression measured and grouped in the study?\",\"answer\":\"Immunohistochemistry assessed HSP60 expression in tumor tissues, and patients were categorized into high- or low-HSP60 expression groups based on staining intensity.\"},{\"question\":\"What relationship does high HSP60 expression have with prognosis?\",\"answer\":\"High HSP60 expression is significantly associated with shorter overall survival and disease-free survival, and multivariate Cox analysis identifies HSP60 as an independent prognostic factor.\"}]","Identification and Clinical Validation of High HSP60 Expression Predicts Poor Prognosis in Patients with Ovarian Cancer | PDF",1790169099,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da1eb36a6d4777526ee3565f60a2ce4a.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a97600d63196f2cbe293ea1c87fa2d72.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8bc783d28f24a7ebd7eda4d03ebbbb51.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dbfac16e71e7f28be2f175e422ea561b.webp",980,1268]